To explore the characteristics of immune cell infiltration in clinical samples, we collected PBMCs from 5 AML patients and 5 healthy donors to detect the proportion of CD4+T cells, CD8+T cells, B cells and CD56+ NK cells. This evidence concerns the gene CD8A and acute myeloid leukemia.